360 related articles for article (PubMed ID: 31804769)
1. Role of ocular cytology in vernal keratoconjunctivitis.
Bruschi G; Ghiglioni DG; Osnaghi S; Rosazza C; Pires Marafon D; Landi M; Marchisio PG
Immun Inflamm Dis; 2020 Mar; 8(1):3-7. PubMed ID: 31804769
[TBL] [Abstract][Full Text] [Related]
2. Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis.
Vichyanond P; Kosrirukvongs P
Curr Allergy Asthma Rep; 2013 Jun; 13(3):308-14. PubMed ID: 23625179
[TBL] [Abstract][Full Text] [Related]
3. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.
Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E
Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058
[TBL] [Abstract][Full Text] [Related]
4. Vernal Keratoconjunctivitis: A Systematic Review.
Bruschi G; Ghiglioni DG; Cozzi L; Osnaghi S; Viola F; Marchisio P
Clin Rev Allergy Immunol; 2023 Aug; 65(2):277-329. PubMed ID: 37658939
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis.
Wan Q; Tang J; Han Y; Wang D; Ye H
Ophthalmic Res; 2018; 59(3):126-134. PubMed ID: 28803239
[TBL] [Abstract][Full Text] [Related]
6. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children.
Labcharoenwongs P; Jirapongsananuruk O; Visitsunthorn N; Kosrirukvongs P; Saengin P; Vichyanond P
Asian Pac J Allergy Immunol; 2012 Sep; 30(3):177-84. PubMed ID: 23156846
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine effects on clinical findings and impression cytology specimens in severe vernal keratoconjunctivitis.
Avunduk AM; Avunduk MC; Erdöl H; Kapicioglu Z; Akyol N
Ophthalmologica; 2001; 215(4):290-3. PubMed ID: 11399937
[TBL] [Abstract][Full Text] [Related]
8. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.
Vichyanond P; Pacharn P; Pleyer U; Leonardi A
Pediatr Allergy Immunol; 2014 Jun; 25(4):314-22. PubMed ID: 24438133
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D serum levels in children with vernal keratoconjunctivitis and disease control.
Ghiglioni DG; Bruschi G; Gandini S; Osnaghi S; Peroni D; Marchisio P
Int J Immunopathol Pharmacol; 2019; 33():2058738419833468. PubMed ID: 30843446
[TBL] [Abstract][Full Text] [Related]
10. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
[TBL] [Abstract][Full Text] [Related]
11. A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study.
Leonardi A; Doan S; Amrane M; Ismail D; Montero J; Németh J; Aragona P; Bremond-Gignac D;
Ophthalmology; 2019 May; 126(5):671-681. PubMed ID: 30593775
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of topical cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children.
Keklikci U; Soker SI; Sakalar YB; Unlu K; Ozekinci S; Tunik S
Jpn J Ophthalmol; 2008; 52(5):357-362. PubMed ID: 18991035
[TBL] [Abstract][Full Text] [Related]
13. Allergic conjunctivitis: current concepts on pathogenesis and management.
Sacchetti M; Abicca I; Bruscolini A; Cavaliere C; Nebbioso M; Lambiase A
J Biol Regul Homeost Agents; 2018; 32(1 Suppl. 1):49-60. PubMed ID: 29552874
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of 2% Rebamipide Suspension for Vernal Keratoconjunctivitis: A Clinical Comparison with Topical Immune Modulators Cyclosporine and Tacrolimus.
Malhotra C; Singh H; Jain AK; Gupta A; Ram J
Ocul Immunol Inflamm; 2022 Jul; 30(5):1083-1091. PubMed ID: 33764241
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Safety and Efficacy of Tacrolimus 0.1% in Severe Pediatric Vernal Keratoconjunctivitis.
Caputo R; Marziali E; de Libero C; Di Grande L; Danti G; Virgili G; Villani E; Mori F; Bacci GM; Lucenteforte E; Pucci N
Cornea; 2021 Nov; 40(11):1395-1401. PubMed ID: 34029239
[TBL] [Abstract][Full Text] [Related]
16. High-mobility group box-1 (HMGB-1) and serum soluble receptor for advanced glycation end products (sRAGE) in children affected by vernal keratoconjunctivitis.
Zicari AM; Zicari A; Nebbioso M; Mari E; Celani C; Lollobrigida V; Cesoni Marcelli A; Occasi F; Duse M
Pediatr Allergy Immunol; 2014 Feb; 25(1):57-63. PubMed ID: 24236762
[TBL] [Abstract][Full Text] [Related]
17. Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children.
Tesse R; Spadavecchia L; Fanelli P; Rizzo G; Procoli U; Brunetti L; Cardinale F; Miniello VL; Bellizzi M; Armenio L
Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):330-5. PubMed ID: 19840298
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study.
Pucci N; Caputo R; di Grande L; de Libero C; Mori F; Barni S; di Simone L; Calvani A; Rusconi F; Novembre E
Pediatr Allergy Immunol; 2015 May; 26(3):256-261. PubMed ID: 25712437
[TBL] [Abstract][Full Text] [Related]
19. Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis.
Kheirkhah A; Zavareh MK; Farzbod F; Mahbod M; Behrouz MJ
Eye (Lond); 2011 Jul; 25(7):872-80. PubMed ID: 21475312
[TBL] [Abstract][Full Text] [Related]
20. Vernal keratoconjunctivitis in Thailand.
Kosrirukvongs P; Vichyanond P; Wongsawad W
Asian Pac J Allergy Immunol; 2003 Mar; 21(1):25-30. PubMed ID: 12931748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
